Addition of cyclophosphamide “on demand” to lenalidomide and corticosteroids in patients with relapsed/refractory multiple myeloma – A retrospective review of a single centre experience

ConclusionThe addition of Cy in patients with myeloma progressing on Len-dex was an inexpensive option with manageable toxicity that resulted in a clinically meaningful extension of disease control.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research